Application
CCDC30 Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the CCDC30 antibody detected the CCDC30 protein (arrow).Application
CCDC30 Antibody (N-term) (AP13790a)immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CCDC30 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | CCDC30 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | PFDN6L |
|---|---|
| Alternative Names | CCDC30 PFDN6L Coiled-coil domain-containing protein 30 Prefoldin subunit 6-like protein |
| Molecular Weight(MW) | 91333 Da |
| Tissue Specificity | Expressed in brain, kidney, pancreas, placenta, liver, thymus and prostate |
| Entrez Gene | 728621 |
|---|---|
| Nucleotide Accession | NP_001074319.1 |
Application
CCDC30 Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the CCDC30 antibody detected the CCDC30 protein (arrow).
Application
CCDC30 Antibody (N-term) (AP13790a)immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CCDC30 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
